FNY Investment Advisers, LLC - PHASEBIO PHARMACEUTICALS INC ownership

PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 52 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
FNY Investment Advisers, LLC ownership history of PHASEBIO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$61,00010,0000.02%
Other shareholders

There were no reported owners of PHASEBIO PHARMACEUTICALS INC in Q4 2019.

NameSharesValueWeighting ↓
View complete list of PHASEBIO PHARMACEUTICALS INC shareholders